Antibacterial Activity of the Novel Drug Gepotidacin against <i>Stenotrophomonas maltophilia</i>-An In Vitro and In Vivo Study

<i>Stenotrophomonas maltophilia</i> is increasingly recognized as a nosocomial bacterial pathogen with a multi-drug resistance profile. In this study, the novel drug gepotidacin, the first compound of the novel triazaacenaphthylene topoisomerase inhibitor antibiotics class, was evaluated...

Full description

Saved in:
Bibliographic Details
Main Authors: Maike Isabell Sanders (Author), Eyhab Ali (Author), Jan Buer (Author), Joerg Steinmann (Author), Peter-Michael Rath (Author), Hedda Luise Verhasselt (Author), Lisa Kirchhoff (Author)
Format: Book
Published: MDPI AG, 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available